Home › Concussion › NCT06208813
Creatine Supplementation in Concussion Recovery
Assigned Creatine Ingestion With Usual Diet or Usual Diet Alone.
Who can join
Ages 18 to 35 · All sexes
Full eligibility criteria
Inclusion Criteria: * 18-35 years old with a diagnosed concussion within 72 hours post-injury Exclusion Criteria: * Learning disability, renal disease, mental behavior or migraine history, and current creatine use or have not taken creatine in the past 6 weeks
About the study
The proposed study aims to compare concussion recovery in those supplementing creatine and those not supplementing creatine. Specific aim 1: To compare number of days until asymptomatic between those taking creatine vs. those not taking creatine following a concussion. Hypothesis: The investigators hypothesize that individuals taking creatine will become asymptomatic sooner than those not taking creatine.Specific aim 2: To compare typical concussion assessment scores (i.e., symptom score, mental status, neurocognition, balance, motor coordination, and visual performance) between those taking creatine vs those not taking creatine following a concussion once asymptomatic.Hypothesis: The investigators hypothesize that individuals taking creatine will have better symptom scores, balance, mental status, and neurocognition assessment scores than those not taking creatine once asymptomatic.
The investigators will calculate descriptive statistics for all demographic, days to asymptomatic, and concussion assessments. For specific aim 1, The investigators will calculate a t-test to determine if days to asymptomatic differed in those taking creatine vs. those not taking creatine. For specific aim 2, the investigators will calculate t-tests with Bonferonni corrections to determine if concussion assessment scores (Sport Concussion Office Assessment Tool-6 assessments, CNS Vital Signs, visual assessment) differed in those taking creatine vs. those not taking creatine.
What is being tested
- Creatine (dietary supplement)
Sponsor: San Diego State University · Participants: 20 · Started: Feb 1, 2024
Contact the study team
- Michelle Weber Rawlins, PhD, ATC · Phone: 619-594-1924
Official record on ClinicalTrials.gov — NCT06208813
Locations in the U.S.
| California | San Diego State University, San Diego |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.